MedTech News
.................... by Andrew Celentano
Amyloid-clearing treatment may curb tau buildup for years in Alzheimer’s brain
An analysis of the brain of a deceased Alzheimer’s disease (AD) clinical trial participant found that regions where an anti-amyloid therapy successfully cleared amyloid plaques showed little to no evidence of tau tangles, a hallmark of AD closely linked to neurodegeneration and cognitive decline.
Sound waves guide cultured cells to form vessel-like networks within one week
With the aid of physical forces—in this case, sound—it is possible to actively steer the formation of engineered tissue. For example, sound waves can be used to create functional vascular networks with blood vessel-like structures in vitro. Scientists at the Center for Molecular Biology of Heidelberg University have demonstrated this through their methodology for acoustic manipulation. The team led by Junior Professor Dr. Daniela Duarte Campos also defines quality requirements for generating complex vascularized 3D tissue containing multiple cell types that is relevant, for example, to biomedical studies.
Real-time biosensor measures pH, glucose and lactate in preserved donor livers
More than 100,000 people in the United States are waiting for a lifesaving organ transplant. For patients who need a liver transplant, determining whether a donor liver is healthy enough to transplant is a critical part of the process.
Patient-specific 3D-printed contact lenses in just 20 minutes
A breakthrough combination of new silicone materials and advanced 3D printing technology developed by University of Waterloo researchers could transform how contact lenses are manufactured.
Autonomous Healthcare Receives FDA De Novo Marketing Authorization for Syncron-E™, the First Device in a New FDA Category of Ventilator Waveform Analysis Software
Automated software helps respiratory therapists identify ineffective efforts, the most frequent type of patient-ventilator asynchrony in mechanically ventilated patients
B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
B. Braun Medical Inc. announced the FDA approval of Sugammadex Injection, 200 mg/2 mL (100 mg/mL), AP-rated generic BRIDION®1* (Sugammadex Injection) in the U.S. market.
Newronika picks up CE mark for adaptive deep brain stim
Newronika announced today that it secured CE mark for its latest adaptive deep brain stimulation (aDBS) system.
Contact-free sensors could help track movement symptoms in Parkinson’s disease
Disease progression in people with Parkinson’s disease can be accurately monitored using sensors, removing some of the limitations of wearable technologies, a new study reports.